Invitrogen, Corning, Promega, Cold Spring Harbor Laboratory Press | GenomeWeb

Invitrogen announced that it has introduced the Block-iT RNAi family of products, which include custom synthetic siRNAs, a Dicer system, a transfection kit, and a transcription kit.

“We have seen the impact that RNAi is making and have responded,” Claude Benchimol, senior vice president of R&D at Invitrogen, said in a statement. “We will continue to provide innovative additions to the Block-iT platform.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.